Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 187

Similar articles for PubMed (Select 21981027)

1.

Effect of early EBV and/or CMV viremia on graft function and acute cellular rejection in pediatric liver transplantation.

Indolfi G, Heaton N, Smith M, Mieli-Vergani G, Zuckerman M.

Clin Transplant. 2012 Jan-Feb;26(1):E55-61. doi: 10.1111/j.1399-0012.2011.01535.x. Epub 2011 Oct 10.

PMID:
21981027
2.

Evaluation of children with lympadenopathy.

Ataş E, Kesik V, Fidancı MK, Kısmet E, Köseoğlu V.

Turk Pediatri Ars. 2014 Mar 1;49(1):30-5. doi: 10.5152/tpa.2014.847. eCollection 2014 Mar.

3.

[Infections during the first posttransplant year--experience at Sibenik General Hospital].

Gulin M, Čivljak R, Bilić B, Sušić E, Gulin M.

Acta Med Croatica. 2014 Apr;68(2):121-7. Croatian.

PMID:
26012149
4.

Effects of tofacitinib on lymphocyte sub-populations, CMV and EBV viral load in patients with plaque psoriasis.

Valenzuela F, Papp KA, Pariser D, Tyring SK, Wolk R, Buonanno M, Wang J, Tan H, Valdez H.

BMC Dermatol. 2015 May 8;15:8. doi: 10.1186/s12895-015-0025-y.

5.

CMV Primary Infection Is Associated With Donor-Specific T Cell Hyporesponsiveness and Fewer Late Acute Rejections After Liver Transplantation.

Shi XL, de Mare-Bredemeijer EL, Tapirdamaz Ö, Hansen BE, van Gent R, van Campenhout MJ, Mancham S, Litjens NH, Betjes MG, van der Eijk AA, Xia Q, van der Laan LJ, de Jonge J, Metselaar HJ, Kwekkeboom J.

Am J Transplant. 2015 May 5. doi: 10.1111/ajt.13288. [Epub ahead of print]

PMID:
25943855
6.

Contrast patterns of Cytomegalovirus and Epstein-Barr virus infection in pediatric living-donor liver transplant recipients.

Nafady-Hego H, Elgendy H, Uemoto S.

Exp Clin Transplant. 2015 Apr;13 Suppl 1:75-82.

PMID:
25894132
7.

Delayed-onset cytomegalovirus disease coded during hospital readmission in a multicenter, retrospective cohort of liver transplant recipients.

Santos CA, Brennan DC, Chapman WC, Fraser VJ, Olsen MA.

Liver Transpl. 2015 May;21(5):581-90. doi: 10.1002/lt.24089. Epub 2015 Apr 15.

PMID:
25678072
8.

Full but impaired activation of innate immunity effectors and virus-specific T cells during CMV and EBV disease following cord blood transplantation.

Farnault L, Gertner-Dardenne J, Gondois-Rey F, Michel G, Chambost H, Hirsch I, Olive D.

Bone Marrow Transplant. 2015 Mar;50(3):459-62. doi: 10.1038/bmt.2014.275. Epub 2015 Jan 19. No abstract available.

PMID:
25599160
9.

[Clinical outcomes of allogeneic hematopoietic stem cell transplantation patients with co-activation of cytomegalovirus and Epstein-Barr virus].

Song T, Chen G, Zhang X, Xu Y, Chen J, Wang Y, Ye L, Xu J, Wu D, Miao J.

Zhonghua Yi Xue Za Zhi. 2014 Nov 4;94(40):3135-9. Chinese.

PMID:
25573307
10.

Risk factors of cytomegalovirus infection after pediatric liver transplantation.

Kawano Y, Mizuta K, Sanada Y, Urahashi T, Ihara Y, Okada N, Yamada N, Sasanuma H, Sakuma Y, Taniai N, Yoshida H, Kawarasaki H, Yasuda Y, Uchida E.

Transplant Proc. 2014 Dec;46(10):3543-7. doi: 10.1016/j.transproceed.2014.09.150.

PMID:
25498086
11.

Valganciclovir administration to kidney donors to reduce the burden of cytomegalovirus and epstein-barr virus transmission during transplantation.

Verghese PS, Schmeling DO, Knight JA, Matas AJ, Balfour HH Jr.

Transplantation. 2015 Jun;99(6):1186-91. doi: 10.1097/TP.0000000000000490.

PMID:
25489844
12.

Incidence, risk factors, and outcome of cytomegalovirus viremia and gastroenteritis in patients with gastrointestinal graft-versus-host disease.

Bhutani D, Dyson G, Manasa R, Deol A, Ratanatharathorn V, Ayash L, Abidi M, Lum LG, Al-Kadhimi Z, Uberti JP.

Biol Blood Marrow Transplant. 2015 Jan;21(1):159-64. doi: 10.1016/j.bbmt.2014.10.004. Epub 2014 Oct 16.

13.

Cytomegaloviral infection in solid organ transplant recipients: preliminary report of one transplant center experience.

Hryniewiecka E, Sołdacki D, Pączek L.

Transplant Proc. 2014 Oct;46(8):2572-5. doi: 10.1016/j.transproceed.2014.09.012.

PMID:
25380868
14.

[Complications associated with hyperglycemia in liver transplant patients].

Builes Montaño CE, Montoya JF, Londoño CA, Palacios Bayona KL, Restrepo Gutiérrez JC, Restrepo JG, Arango Toro CM, Jaimes Barragan FA.

Rev Gastroenterol Mex. 2014 Jul-Sep;79(3):180-6. doi: 10.1016/j.rgmx.2014.08.002. Epub 2014 Sep 8. Spanish.

15.

Splenic infarction caused by a rare coinfection of Epstein-Barr virus, cytomegalovirus, and Mycoplasma pneumoniae.

Li Y, Pattan V, Syed B, Islam M, Yousif A.

Pediatr Emerg Care. 2014 Sep;30(9):636-7. doi: 10.1097/PEC.0000000000000211.

PMID:
25186505
16.

Medical management of children after liver transplantation.

Miloh T.

Curr Opin Organ Transplant. 2014 Oct;19(5):474-9. doi: 10.1097/MOT.0000000000000121. Review.

PMID:
25162538
17.

The impact of donor viral replication at transplant on recipient infections posttransplant: a prospective study.

Verghese PS, Schmeling DO, Knight JA, Matas AJ, Balfour HH Jr.

Transplantation. 2015 Mar;99(3):602-8. doi: 10.1097/TP.0000000000000354.

PMID:
25148381
18.

Viral surveillance and subclinical viral infection in pediatric kidney transplantation.

Smith JM, Dharnidharka VR.

Pediatr Nephrol. 2015 May;30(5):741-8. doi: 10.1007/s00467-014-2866-8. Epub 2014 Aug 16.

PMID:
25125226
19.

Impact of Pharmacist Involvement in Early Identification and Enrollment in Patient Assistance Programs on CMV Outcomes in Transplantation.

Byrns JS, Pilch NW, Taber DJ.

J Pharm Pract. 2014 Aug 8. pii: 0897190014544788. [Epub ahead of print]

PMID:
25107422
20.

Therapeutic approach to respiratory infections in lung transplantation.

Clajus C, Blasi F, Welte T, Greer M, Fuehner T, Mantero M.

Pulm Pharmacol Ther. 2015 Jun;32:149-54. doi: 10.1016/j.pupt.2014.07.003. Epub 2014 Jul 17.

PMID:
25038552
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk